Gainers
- Merus NV (NASDAQ: MRUS) shares rose 52.3 percent to $22.85 in pre-market trading. Incyte Corporation (NASDAQ: INCY) and Merus announced a global strategic research collaboration to discover and develop bispecific antibodies.
- Calithera Biosciences Inc (NASDAQ: CALA) rose 17.9 percent to $3.60 in pre-market trading. Bristol-Myers Squibb Co (NYSE: BMY) and Calithera Biosciences disclosed a clinical collaboration to evaluate Opdivo in combination with CB-839 in clear cell renal cell carcinoma.
- InvenSense Inc (NYSE: INVN) shares rose 17 percent to $12.68 in pre-market trading after TDK Corp announced plans to acquire InvenSense for $13 per share in cash.
- Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) shares rose 12.1 percent to $18.30 in pre-market trading after the company disclosed that its Phase 3 trial for sotagliflozin met its primary endpoint.
- Danaos Corporation (NYSE: DAC) shares rose 11.1 percent to $3.00 in pre-market trading after gaining 1.85 percent on Tuesday.
- Inovio Pharmaceuticals Inc (NASDAQ: INO) shares rose 11 percent to $7.69 in pre-market trading following Phase 1 Zika vaccine update.
- Winnebago Industries, Inc. (NYSE: WGO) rose 5.9 percent to $39.40 in pre-market trading after the company reported upbeat Q1 results.
- Embraer SA (ADR) (NYSE: ERJ) rose 5.2 percent to $18.67 in pre-market trading after declining 1.61 percent on Tuesday.
- China Eastern Airlines Corp. Ltd. (ADR) (NYSE: CEA) rose 4.1 percent to $22.3 in pre-market trading after slipping 0.42 percent on Tuesday.
- Nike Inc (NYSE: NKE) shares rose 2.3 percent to $53.00 in pre-market trading as the company posted stronger-than-expected results for its second quarter on Tuesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.
ENTER TO WIN $500 IN STOCK OR CRYPTO
Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!
Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.
Losers
- xG Technology Inc (NASDAQ: XGTI) shares fell 54.7 percent to $1.64 in pre-market trading after the company reported the pricing of its $10 million offering.
- Merrimack Pharmaceuticals Inc (NASDAQ: MACK) fell 20.9 percent to $4.25 in pre-market trading after the company announced that it will stop a Phase 2 study of its treatment to fight breast cancer.
- Finish Line Inc (NASDAQ: FINL) shares fell 14.8 percent to $19.60 in pre-market trading after the company reported weaker-than-expected results for its fiscal third quarter and issued a downbeat forecast.
- Sigma Designs Inc (NASDAQ: SIGM) fell 12.9 percent to $5.05 in pre-market trading.
- RedHill Biopharma Ltd - ADR (NASDAQ: RDHL) fell 12.1 percent to $9.50 in pre-market trading. RedHill Biopharma reported a proposed concurrent public offering and registered direct offering.
- Steelcase Inc. (NYSE: SCS) shares fell 9.5 percent to $15.20 in pre-market trading after the company reported weak results for its third quarter.
- Advanced Accelerator Application SA(ADR) (NASDAQ: AAAP) shares fell 8.4 percent to $24.00 in pre-market trading after the company disclosed that it has received a Complete Response Letter from the FDA for Lutathera.
- Delta Air Lines, Inc. (NYSE: DAL) shares fell 3.5 percent to $49.00 in pre-market trading. Delta Air Lines and Aeroméxico agreed to establish a joint cooperation agreement.
- Accenture Plc (NYSE: ACN) fell 3.3 percent to $120.00 in pre-market trading after the company issued a weak outlook for the full year.
- FedEx Corporation (NYSE: FDX) fell 2.4 percent to $194.00 in pre-market trading after the company reported weaker-than-expected earnings for its second quarter on Tuesday.
Crypto Whales Are Loading Up — Are You?
New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.